Veriphi

Veriphi is rated 3 out of 5 in the category medical devices. Read and write reviews about Veriphi. Veriphi has developed a ground breaking laser based analyser that minimises the risk of intravenous medication error in hospitals. The company is seeking to raise up to NZ$2m to commercialise its solution. Medical error is the third leading cause of death in the United States and medication error is one of the most common forms of patient harm in hospitals globally. Intravenous errors are twice as likely to harm patients than from drugs administered via other routes. As drug regimens for an aging population become more complex, new intelligent solutions are required to minimise the risk of patient harm whilst fitting seamlessly with existing clinical practice. The Veriphi system will do just that using lasers to automatically verify the drug identity and concentration. Veriphi will verify IV drug doses as they are compounded or administered and be paid every time that happens, providing greater safety by being seamless within existing clinical practise.